Lineage to Present at B. Riley Securities 2022 Neuro & Ophthalmology Virtual Investor Conference on April 27, 2022Business Wire • 04/26/22
Lineage Announces a Fifth Cell Therapy Program: Allogeneic Photoreceptor Transplants for the Treatment of Diseases Which May Lead to BlindnessBusiness Wire • 04/25/22
Lineage and Cancer Research UK Announce Completion of Patient Enrollment in Phase 1 Clinical Study of VAC2 for the Treatment of Non-small Cell Lung CancerBusiness Wire • 04/13/22
Lineage to Present at the 2022 Virtual Growth Conference Presented by Maxim Group LLC on March 28, 2022Business Wire • 03/24/22
Lineage Announces Pipeline Expansion to Include Auditory Neuronal Cell Therapy for Treatment of Hearing LossBusiness Wire • 03/21/22
Lineage Cell Therapeutics, Inc. (LCTX) CEO Brian Culley on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 03/11/22
Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business UpdateBusiness Wire • 03/10/22
Lineage Cell Therapeutics to Report Fourth Quarter and Full Year 2021 Financial Results and Provide Business Update on March 10, 2022Business Wire • 03/01/22
Lineage to Present at B. Riley Securities 2022 Virtual Oncology Conference on January 27, 2022Business Wire • 01/24/22
Lineage Cell Therapeutics to Present at H.C. Wainwright Bioconnect Virtual ConferenceBusiness Wire • 01/04/22
Lineage Establishes Exclusive Worldwide Collaboration With Genentech for the Development and Commercialization of OpRegen® RPE Cell Therapy for the Treatment of Ocular DisordersBusiness Wire • 12/20/21
OpRegen® Clinical Data Presented at 125th Annual American Academy of Ophthalmology Meeting by Michael S. Ip, M.D.Business Wire • 11/15/21
Lineage Cell Therapeutics, Inc. (LCTX) CEO Brian Culley on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 11/11/21
Lineage Reports Third Quarter 2021 Financial Results and Highlights Progress From Clinical Cell Therapy ProgramsBusiness Wire • 11/10/21
Lineage Cell Therapeutics to Report Third Quarter 2021 Financial Results and Provide Business Update on November 10, 2021Business Wire • 11/03/21
Analysts Estimate Lineage Cell (LCTX) to Report a Decline in Earnings: What to Look Out forZacks Investment Research • 10/27/21